The hygromycin B phosphotransferase gene from and the pyrithiamine resistance gene from are two dominant selectable marker genes widely used to genetically manipulate several fungal species. Despite the recent development of CRISPR/Cas9 and marker-free systems, in vitro molecular tools to study , which is a saprophytic fungus causing life-threatening diseases in immunocompromised hosts, still rely extensively on the use of dominant selectable markers. The limited number of drug selectable markers is already a critical aspect, but the possibility that their introduction into a microorganism could induce enhanced virulence or undesired effects on metabolic behavior constitutes another problem. In this context, here, we demonstrate that the use of in leads to the secretion of a compound that allows the recovery of thiamine auxotrophy. In this study, we developed a simple modification of the two commonly used dominant markers in which the development of resistance can be controlled by the xylose-inducible promoter from . This strategy provides an easy solution to avoid undesired side effects, since the marker expression can be readily silenced when not required.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305790 | PMC |
http://dx.doi.org/10.3390/jof7070506 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!